Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Allison K. Ehrlich
Is Chronic AhR Activation by Rapidly Metabolized Ligands Safe for the Treatment of Immune-Mediated Diseases?
Current Opinion in Toxicology
Toxicology
Related publications
Benzimidazoisoquinolines: A New Class of Rapidly Metabolized Aryl Hydrocarbon Receptor (AhR) Ligands That Induce AhR-Dependent Tregs and Prevent Murine Graft-Versus-Host Disease
PLoS ONE
Multidisciplinary
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
Journal of Immunology
Allergy
Immunology
MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Genetics of Immune-Mediated Inflammatory Diseases
Clinical and Experimental Immunology
Allergy
Immunology
Drug Utilization of Biological Drugs in the Treatment of Chronic Immune-Mediated Inflammatory Diseases (IMIDs): An Observational Study on Italian Patients
Global and Regional Health Technology Assessment
Health Policy
The Microbiota and Immune‐mediated Diseases: Opportunities for Therapeutic Intervention
European Journal of Immunology
Allergy
Immunology
HIV-associated Chronic Immune Activation
Immunological Reviews
Allergy
Immunology
Editorial: Microbial Translocation and Immune Activation Profiling During Treatment of Chronic HCV
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
The Gut Microbiota in Immune-Mediated Inflammatory Diseases
Frontiers in Microbiology
Microbiology